These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37644514)

  • 1. Abnormal DNA methylation analysis of leucine-rich glioma-inactivated 1 antibody encephalitis reveals novel methylation-driven genes related to prognostic and clinical features.
    Qiao S; Sun Q; Li H; Yin J; Wang A; Zhang S
    Clin Epigenetics; 2023 Aug; 15(1):139. PubMed ID: 37644514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leucine-Rich Glioma-Inactivated 1 (LGI1) Protein Stimulates Proliferation and IL-10 Production in Peripheral Blood Mononuclear Cells of Patients with LGI1 Antibody-Mediated Autoimmune Encephalitis In Vitro.
    Goihl A; Reinhold D; Reinhold A; Schraven B; Körtvelyessy P
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines/chemokines and immune checkpoint molecules in anti-leucine-rich glioma-inactivated 1 encephalitis.
    Qiao S; Zhang SC; Li HY; Wang ZH; Jin Y; Wang AH; Liu XW
    Neurol Sci; 2023 Mar; 44(3):1017-1029. PubMed ID: 36445543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients.
    Lin YT; Yang X; Lv JW; Liu XW; Wang SJ
    Neuropsychiatr Dis Treat; 2019; 15():2909-2915. PubMed ID: 31632040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and CSF cytokine levels mirror different neuroimmunological mechanisms in patients with LGI1 and Caspr2 encephalitis.
    Körtvelyessy P; Goihl A; Guttek K; Schraven B; Prüss H; Reinhold D
    Cytokine; 2020 Nov; 135():155226. PubMed ID: 32799011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2.
    Murayama A; Sugaya K; Hara M; Kawazoe T; Tobisawa S; Nakajima H; Takahashi K
    Intern Med; 2023 Jun; 62(11):1659-1663. PubMed ID: 36223927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal B-cell activation in LGI1 antibody encephalitis.
    Lehmann-Horn K; Irani SR; Wang S; Palanichamy A; Jahn S; Greenfield AL; Dandekar R; Lepennetier G; Michael S; Gelfand JM; Geschwind MD; Wilson MR; Zamvil SS; von Büdingen HC
    Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 32029531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Features and Gut Microbial Alterations in Anti-leucine-rich Glioma-Inactivated 1 Encephalitis-A Pilot Study.
    Ma X; Ma L; Wang Z; Liu Y; Long L; Ma X; Chen H; Chen Z; Lin X; Si L; Chen X
    Front Neurol; 2020; 11():585977. PubMed ID: 33193049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides.
    Seery N; Butzkueven H; O'Brien TJ; Monif M
    Autoimmun Rev; 2022 May; 21(5):103074. PubMed ID: 35247644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.
    Müller-Jensen L; Zierold S; Versluis JM; Boehmerle W; Huehnchen P; Endres M; Mohr R; Compter A; Blank CU; Hagenacker T; Meier F; Reinhardt L; Gesierich A; Salzmann M; Hassel JC; Ugurel S; Zimmer L; Banks P; Spain L; Soon JA; Enokida T; Tahara M; Kähler KC; Seggewiss-Bernhardt R; Harvey C; Long GV; Schöberl F; von Baumgarten L; Hundsberger T; Schlaak M; French LE; Knauss S; Heinzerling LM
    Eur J Cancer; 2022 Nov; 175():224-235. PubMed ID: 36155116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
    Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
    Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The active intrathecal B-cell response in LGI1-antibody encephalitis.
    Irani SR; Lehmann-Horn K; Geschwind M; Wang S; Vincent A; von Büdingen HC
    Lancet; 2015 Feb; 385 Suppl 1():S46. PubMed ID: 26312868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the functional outcomes of anti-LGI1 encephalitis using a random forest model.
    Li G; Liu X; Wang M; Yu T; Ren J; Wang Q
    Acta Neurol Scand; 2022 Aug; 146(2):137-143. PubMed ID: 35373330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
    Huang X; Fan C; Gao L; Li L; Ye J; Shen H
    J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
    Bastiaansen AEM; van Sonderen A; Titulaer MJ
    Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
    Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
    Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
    [No Abstract]   [Full Text] [Related]  

  • 17. What Is Different about Teratoma-Associated Anti-LGI1 Encephalitis? A Long-Term Clinical and Neuroimaging Case Series.
    Li C; Cai HB; Zhao X; Xi XC; Zhou Q; Luo HY; Tang ZP; Kang HC; Kirsch HE
    Eur Neurol; 2022; 85(6):437-445. PubMed ID: 35896086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF Findings in Chinese Patients with NMDAR, LGI1 and GABABR Antibody-Associated Encephalitis.
    Qiao S; Li H; Cui C; Zhang C; Wang A; Jiang W; Zhang S
    J Inflamm Res; 2024; 17():1765-1776. PubMed ID: 38523682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-leucine-rich glioma inactivated protein 1 encephalitis with sleep disturbance as the first symptom: A case report and review of literature.
    Kong DL
    World J Clin Cases; 2023 Jan; 11(2):408-416. PubMed ID: 36686352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features and outcomes in relapsing and monophasic patients with anti-leucine-rich glioma-inactivated 1 encephalitis].
    Li JM; Ma XR; Peng T; Li JH; Lu H
    Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(25):1947-1951. PubMed ID: 32629594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.